|
Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs |
Farrell R J, Smiddy P F, Pilkington R M, Tobin A A, Mooney E E, Temperley I J, McDonald G S, Bowmer H A, Wilson G F, Kelleher D |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Farrell R J, Smiddy P F, Pilkington R M, Tobin A A, Mooney E E, Temperley I J, McDonald G S, Bowmer H A, Wilson G F, Kelleher D. Guided versus blind liver biopsy for chronic hepatitis C: clinical benefits and costs. Journal of Hepatology 1999; 30(4): 580-587 Indexing Status Subject indexing assigned by NLM MeSH Adult; Automation; Autopsy; Biopsy, Needle /adverse effects /economics /methods; Costs and Cost Analysis; Equipment Design; Female; Hemophilia A /complications; Hepatitis C, Chronic /economics /etiology /pathology; Humans; Ireland; Liver /pathology /ultrasonography /virology; Male; Morbidity; Needles; Pain; von Willebrand Diseases /complications AccessionNumber 21999000645 Date bibliographic record published 27/11/1999 |
|
|
|